glucagon has been researched along with Multiple Organ Failure in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harinck, HI; Romijn, JA; van Lennep, JR | 1 |
Heep, J; Holm, E; Leweling, H; Staedt, U; Tschepe, A | 1 |
Burman, KD; Kushner, J | 1 |
Arnold, J; Campbell, IT; Chadwick, S; Hipkin, LJ; Jenkins, S; Keegan, M; O'Sullivan, E | 1 |
Baue, AE; Durham, RM; Mazuski, JE | 1 |
Clark, SJ; Croos, P; Miell, J; Seed, PT; Shojaee-Moradie, F; Umpleby, AM; Wendon, JA | 1 |
Lindberg, I; Sarac, MS; Zieske, AW | 1 |
1 review(s) available for glucagon and Multiple Organ Failure
Article | Year |
---|---|
Clinical trials of new and novel therapeutic agents.
Topics: Antithrombin III; Clinical Trials as Topic; Combined Modality Therapy; Critical Care; Glucagon; Growth Substances; Humans; Inflammation Mediators; Ketoconazole; Life Support Care; Multiple Organ Failure; Systemic Inflammatory Response Syndrome; Treatment Outcome | 1996 |
6 other study(ies) available for glucagon and Multiple Organ Failure
Article | Year |
---|---|
Multi-organ failure after a glucagon test.
Topics: Adrenal Gland Neoplasms; Adult; Diabetes Mellitus, Type 2; Diagnosis, Differential; Glucagon; Humans; Hypertension; Injections, Intravenous; Male; Multiple Organ Failure; Pheochromocytoma; Treatment Outcome | 2007 |
[Amino acid metabolism in infection].
Topics: Amino Acids; Animals; Catecholamines; Extracellular Space; Glucagon; Humans; Infections; Intracellular Fluid; Liver; Multiple Organ Failure; Muscles; Rats; Sepsis; Shock, Septic | 1983 |
Can catabolism be reversed and survival enhanced by altering glucose, somatostatin, and glucagon levels in systemically ill patients?
Topics: Blood Glucose; Glucagon; Humans; Infusions, Intravenous; Insulin; Multiple Organ Failure; Somatostatin | 1995 |
Manipulation of substrate utilization with somatostatin in patients with secondary multiple organ dysfunction syndrome.
Topics: Aged; Calorimetry, Indirect; Energy Metabolism; Female; Glucagon; Glucose; Glucose Clamp Technique; Growth Hormone; Humans; Hydrocortisone; Infusions, Intravenous; Insulin; Male; Middle Aged; Multiple Organ Failure; Somatostatin | 1995 |
Temporal changes in insulin sensitivity following the development of acute liver failure secondary to acetaminophen.
Topics: Acetaminophen; Adult; Blood Glucose; C-Peptide; Fatal Outcome; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Kinetics; Liver Failure, Acute; Male; Metabolic Clearance Rate; Middle Aged; Multiple Organ Failure | 2001 |
The lethal form of Cushing's in 7B2 null mice is caused by multiple metabolic and hormonal abnormalities.
Topics: Adrenocorticotropic Hormone; Animals; Blood Glucose; Cause of Death; Corticosterone; Cushing Syndrome; Glucagon; Glucose; Glycogen; Hormones; Hypothermia; Lactic Acid; Liver; Magnesium; Metyrapone; Mice; Mice, Knockout; Multiple Organ Failure; Nerve Tissue Proteins; Neuroendocrine Secretory Protein 7B2; Pituitary Hormones; Radioimmunoassay; Seizures; Tissue Distribution | 2002 |